A leader in patent litigation, Powell Gilbert LLP frequently represents life sciences clients in complex, high-value cases across Europe, including before the UPC. The practice is also well-placed to handle IP advisory matters related to patents, trade marks, design rights, copyright, and confidential information. The practice is led by dual-qualified (England and Ireland) Penny Gilbert, an experienced pharma and biotech patent litigator and UPC representative. Bryce Matthewson and Peter Fitzpatrick, also litigators, were promoted to partners in 2024. Tim Powell is no longer at the firm.
Legal 500 Editorial commentary
Accolades
Client satisfaction
Key clients
- BioNTech
- Biogen Inc
- Samsung Bioepis
- Edwards Lifesciences
- Glenmark Pharmaceuticals
- DSM IP Assets B.V.
- DSM Nutritional Products AG
- UCB Biopharma
- LTS Lohman
- Nador Cott Protection S.A.S. (NCP)
Work highlights
Representing Edwards Lifesciences in an international patent dispute with Meril Life Sciences in respect of Meril’s Myval, Myval Octacor, and Myval Octapro transcatheter heart valve systems.
Representing Samsung Bioepis in two related sets of proceedings concerning patents owned by Regeneron and Bayer relating to formulations for and the use of aflibercept to treat certain patients with wet age-related macular degeneration or diabetic retinopathy.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Practice head
Penny Gilbert
Other key lawyers
Zoë Butler; Tim Whitfield; Bryce Matthewson; Pete Damerell; Peter Fitzpatrick; Bethan Hopewell; Sidd Kusumakar